• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oncocyte Corporation - Common Stock (NQ:OCX)

3.200 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Oncocyte Corporation - Common Stock

OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For... 
Via TheNewswire.com
News headline image
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Penny stocks are a risky business but following the insiders to your next trade can alleviate some of the risks; these are the three hottest insider buys. 
Via MarketBeat
News headline image
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
September 18, 2023
Via ACCESSWIRE
News headline image
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
Via ACCESSWIRE
News headline image
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
August 28, 2023
Via ACCESSWIRE
News headline image
Oncocyte Reports Second Quarter 2023 Financial Results
August 10, 2023
Via ACCESSWIRE
News headline image
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
August 08, 2023
Via ACCESSWIRE
News headline image
Oncocyte Regains Compliance With Nasdaq Listing Requirements
August 09, 2023
Via ACCESSWIRE
News headline image
Oncocyte To Announce Second Quarter 2023 Financial Results
August 03, 2023
Via ACCESSWIRE
News headline image
EchelonDx and Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test Offerings
June 15, 2021
From Echelon Diagnostics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap